OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Relationship between Trop-2, Chemotherapeutic Drugs, and Chemoresistance
Tomas Koltai, Larry Fliegel
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 87-87
Open Access | Times Cited: 5
Tomas Koltai, Larry Fliegel
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 87-87
Open Access | Times Cited: 5
Showing 5 citing articles:
Advances in Trop-2 targeted antibody-drug conjugates for breast cancer: mechanisms, clinical applications, and future directions
Yujun Tong, Xiaobing Fan, Huan Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Yujun Tong, Xiaobing Fan, Huan Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Exploring the Prognostic Role of Trop-2, CD47, and CD163 Expression Levels on Survival Outcomes in Patients with Triple-Negative Breast Cancer
Ramazan Oğuz Yüceer, Selda Aydın, Iclal Gelir, et al.
Diagnostics (2025) Vol. 15, Iss. 2, pp. 232-232
Open Access
Ramazan Oğuz Yüceer, Selda Aydın, Iclal Gelir, et al.
Diagnostics (2025) Vol. 15, Iss. 2, pp. 232-232
Open Access
Folate Receptor, Trop 2, Ovarian Cancer, and Antibody-Drug Conjugate (ADC)
Chinmoy K Bose, N Basu
Indian Journal of Medical and Paediatric Oncology (2025)
Open Access
Chinmoy K Bose, N Basu
Indian Journal of Medical and Paediatric Oncology (2025)
Open Access
The interplay between COX-2, chemotherapeutic drugs, and chemoresistance in colon cancer
Sally M. Shalaby, Salma Ahmed Shawky, Hassan Ashour, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Sally M. Shalaby, Salma Ahmed Shawky, Hassan Ashour, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Correlation between trophoblast cell-surface antigen-2 (Trop-2) expression and pathological complete response in patients with HER2-positive early breast cancer treated with neoadjuvant docetaxel, carboplatin, trastuzumab, and pertuzumab
María Gión, Juan Garcia, Jose Manuel Perez‐García, et al.
Breast Cancer Research and Treatment (2024) Vol. 205, Iss. 3, pp. 589-598
Open Access | Times Cited: 3
María Gión, Juan Garcia, Jose Manuel Perez‐García, et al.
Breast Cancer Research and Treatment (2024) Vol. 205, Iss. 3, pp. 589-598
Open Access | Times Cited: 3
Sacituzumab govitecan in triple-negative breast cancer: from bench to bedside, and back
Valentina Rossi, Alessandra Turati, Antonio Rosato, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Valentina Rossi, Alessandra Turati, Antonio Rosato, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
